# A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects

> **NCT02155504** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 44 (actual)

## Conditions studied

- Healthy Volunteers
- Pharmacokinetics of ASP3700

## Interventions

- **DRUG:** ASP3700
- **DRUG:** itraconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02155504
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2014-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02155504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02155504, "A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02155504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*